Junwei Han

Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Network Analysis

Gene Expression

Top Venues

Briefings in bioinformatics

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiashuo Wu, Xilong Zhao, Yalan He, Bingyue Pan, Jiyin Lai, Miao Ji, Siyuan Li, Junling Huang, Junwei Han
IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data. Briefings in bioinformatics 25 (4) (2024)
Jiashuo Wu, Xilong Zhao, Yalan He, Bingyue Pan, Jiyin Lai, Miao Ji, Siyuan Li, Junling Huang, Junwei Han
IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data. Briefings in bioinformatics 25 (4) (2024)
Yuqi Sheng, Jiashuo Wu, Xiangmei Li, Jiayue Qiu, Ji Li, Qinyu Ge, Liang Cheng, Junwei Han
iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. Briefings in bioinformatics (2023)
Jiashuo Wu, Ji Li, Yalan He, Junling Huang, Xilong Zhao, Bingyue Pan, Yahui Wang, Liang Cheng, Junwei Han
DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing. GigaScience 12 (2023)
Jiashuo Wu, Ji Li, Yalan He, Junling Huang, Xilong Zhao, Bingyue Pan, Yahui Wang, Liang Cheng, Junwei Han
DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing. GigaScience 12 (2023)
Jiashuo Wu, Ji Li, Yalan He, Junling Huang, Xilong Zhao, Bingyue Pan, Yahui Wang, Liang Cheng, Junwei Han
DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing. GigaScience 12 (2023)
Yuqi Sheng, Jiashuo Wu, Xiangmei Li, Jiayue Qiu, Ji Li, Qinyu Ge, Liang Cheng, Junwei Han
iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. Briefings in bioinformatics 24 (2) (2023)
Jiashuo Wu, Ji Li, Yalan He, Junling Huang, Xilong Zhao, Bingyue Pan, Yahui Wang, Liang Cheng, Junwei Han
DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing. GigaScience 12 (2023)
Yuqi Sheng, Jiashuo Wu, Xiangmei Li, Jiayue Qiu, Ji Li, Qinyu Ge, Liang Cheng, Junwei Han
iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. Briefings in bioinformatics 24 (2) (2023)
Jiashuo Wu, Xiangmei Li, Qian Wang, Junwei Han
DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network. Bioinformatics (Oxford, England) 38 (21) (2022)
Ji Li, Jiashuo Wu, Junwei Han
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. Genes 14 (1) (2022)
Junwei Han, Yang Yang, Xiangmei Li, Jiashuo Wu, Yuqi Sheng, Jiayue Qiu, Qian Wang, Ji Li, Yalan He, Liang Cheng, Yan Zhang
Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironment. Molecular oncology 16 (11) (2022)
Ji Li, Jiashuo Wu, Junwei Han
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. Genes 14 (1) (2022)
Ji Li, Jiashuo Wu, Junwei Han
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. Genes 14 (1) (2022)
Jiayue Qiu, Xiangmei Li, Yalan He, Qian Wang, Ji Li, Jiashuo Wu, Ying Jiang, Junwei Han
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. Journal of translational medicine 20 (1) (2022)
Xiangmei Li, Yalan He, Jiashuo Wu, Jiayue Qiu, Ji Li, Qian Wang, Ying Jiang, Junwei Han
A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy. Briefings in bioinformatics 23 (5) (2022)
Jiayue Qiu, Xiangmei Li, Yalan He, Qian Wang, Ji Li, Jiashuo Wu, Ying Jiang, Junwei Han
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. Journal of translational medicine 20 (1) (2022)
Jiayue Qiu, Xiangmei Li, Yalan He, Qian Wang, Ji Li, Jiashuo Wu, Ying Jiang, Junwei Han
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. Journal of translational medicine 20 (1) (2022)
Jiayue Qiu, Xiangmei Li, Yalan He, Qian Wang, Ji Li, Jiashuo Wu, Ying Jiang, Junwei Han
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. Journal of translational medicine 20 (1) (2022)
Ji Li, Jiayue Qiu, Junwei Han, Xiangmei Li, Ying Jiang
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures. Genes 13 (11) (2022)
Yuqi Sheng, Ying Jiang, Yang Yang, Xiangmei Li, Jiayue Qiu, Jiashuo Wu, Liang Cheng, Junwei Han
CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer. Briefings in bioinformatics 22 (5) (2021)
Jieyi Di, Baotong Zheng, Qingfei Kong, Ying Jiang, Siyao Liu, Yang Yang, Xudong Han, Yuqi Sheng, Yunpeng Zhang, Liang Cheng, Junwei Han
Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities. Molecular oncology 13 (10) (2019)
Junwei Han, Siyao Liu, Ying Jiang, Chaohan Xu, Baotong Zheng, Minghao Jiang, Haixiu Yang, Fei Su, Chun-Quan Li, Yunpeng Zhang
Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer. Journal of cellular and molecular medicine 22 (9) (2018)